CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Capital Blue Cross

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
B
Index (ASP = 100)
102.7
Vs. acquisition
+-0.0%
Brand index
102.7
Biosimilar index
103.6
Contract variability
Low
Drugs observed
924
States
35

Contracts above the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 92% of billing volume on the single most common rate — a card system — a few standard rates, most practices on the standard one.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.